Human TCR (TCRCD8-CMV#12) recognizes CMV pp65 peptide (NLVPMVATV) in the context of HLA-A0201. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABC-118 | Recombinant Human Anti-CMV pp65 Antibody (MO61) | BL | IgG |
MRO-1568CQ | Recombinant Mouse Anti-CMV pp65 Antibody (9L143) | IF | Mouse antibody |
MRO-1569CQ | Recombinant Mouse Anti-CMV pp65 Antibody (B2) | ELISA, WB | Mouse antibody |
MRO-1570CQ | Recombinant Mouse Anti-CMV pp65 Antibody (CH12) | WB, IF | Mouse antibody |
MRO-1571CQ | Recombinant Mouse Anti-CMV pp65 Antibody (VMC93) | IF | Mouse antibody |
There are currently no Customer reviews or questions for VS-0622-YF3057. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.